HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life

Condition:   ADPKD Interventions:   Drug: Hydrochlorothiazide 25 mg;   Drug: Placebo Sponsor:   University Medical Center Groningen Not yet recruiting

Source: ClinicalTrials.gov - May 13, 2022 Category: Research Source Type: clinical trials